0001140361-17-032398.txt : 20170816 0001140361-17-032398.hdr.sgml : 20170816 20170816121719 ACCESSION NUMBER: 0001140361-17-032398 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170816 DATE AS OF CHANGE: 20170816 EFFECTIVENESS DATE: 20170816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-292913 FILM NUMBER: 171035751 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0708 D LIVE 0001359931 PROTEON THERAPEUTICS INC 200 WEST STREET WALTHAM MA MASSACHUSETTS 02451 781-890-0102 DELAWARE None None Corporation true Timothy P. Noyes c/o Proteon Therpeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Executive Officer Director Mr. Noyes is the President and Chief Executive Officer of the Issuer. George A. Eldridge c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Executive Officer Mr. Eldridge is the Chief Financial Officer, Senior Vice President, Treasurer and Assistant Secretary of the Issuer. Matthew P. Kowalsky c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Executive Officer Mr. Kowalsky is the Vice President of Legal and the Secretary of the Issuer. Steven K. Burke, M.D. c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Executive Officer Dr. Burke is a Senior Vice President and the Chief Medical Officer of the Issuer. Paul J. Hastings c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Director Hubert Birner, Ph. D. c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Director Garen Bohlin c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Director Scott A. Canute c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Director John G. Freund, M.D. c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Director Tim Haines c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Director Tony Kingsley c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Director Jonathan Leff c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Director Daniel P. Gottlieb c/o Proteon Therapeutics Inc. 200 West Street Waltahm MA MASSACHUSETTS 02451 Executive Officer Mr. Gottlieb is the Vice President of Corporate Development of the Issuer. E. Scott Toner c/o Proteon Therapeutics Inc. 200 West Street Waltham MA MASSACHUSETTS 02451 Executive Officer Mr. Toner is the Senior Vice President of Marketing of the Issuer. Biotechnology Decline to Disclose 06b false 2017-08-02 false true true true true Series A Convertible Preferred Stock which is convertible into Common Stock, $.001 par value. false 0 22000000 22000000 0 false 11 0 0 0 false PROTEON THERAPEUTICS INC /s/ George A. Eldridge George A. Eldridge Sr. V.P. and Chief Financial Officer of the Issuer 2017-08-16